ELISA Blocking Solution

Cat. No.: E615777

Storage

Store at 2-8°C

Shipped In

Wet ice

Specifications

保管条件

Store at 2-8°C

入荷

Wet ice

この製品は冷冷この冷このこの製品の運送が必要です。地上およびその他の経済サービスは利用できません。

Application Protocols

Tested applications, recommended dilutions, and detailed step-by-step protocols are not specified for this item. Refer to the product label and CoA/Spec Sheet for any item-specific instructions.

General note: Blocking is typically incorporated after plate coating and washing, prior to sample incubation in ELISA workflows. However, follow your validated laboratory SOP or the manufacturer’s datasheet for precise conditions.

Biological Roles

Blocking solutions function by leveraging general biomolecular interactions to passivate assay surfaces; they are not intended to exert biological activity in cells or organisms.

Mechanistic context (literature):

• Protein adsorption: Proteins or polymers in blocking solutions adsorb onto hydrophobic polystyrene via hydrophobic and van der Waals interactions, and onto charged sites via electrostatic interactions, thereby occupying nonspecific binding sites.
• Epitope preservation: Proper blockers minimize conformational changes to immobilized capture proteins, helping preserve native epitopes for antibody recognition.
• Matrix compatibility: Choice of blocker can influence cross-reactivity with sample matrices (serum, plasma, cell lysate). For example, milk-based blockers may contain endogenous biotin and immunoglobulins that can interfere with certain detection systems (HRP/streptavidin or anti-mouse secondary antibodies) — considerations apply generally and should be validated per assay.

This product is for research use only and is not intended for use in diagnostic procedures or therapeutic applications.

Buffer Applications

Primary application: surface blocking in ELISA microplates to reduce nonspecific binding and background signal.

General usage guidance (literature-based; not product-specific instructions):

• When to block: After coating the plate with antigen or capture antibody and washing away unbound material.
• Typical conditions: Incubate with blocking solution for 30–120 minutes at room temperature with gentle agitation, or overnight at 2–8°C for maximal passivation. Optimize empirically.
• Volume per well: Use sufficient volume to fully cover the well surface (e.g., 200–300 µL for standard 96-well plates) to ensure uniform coverage.
• Post-blocking: Remove the blocker and proceed directly to sample incubation without rinsing, unless your validated method specifies a wash. Some protocols retain a small percentage of blocker in antibody/sample diluents to maintain low background.
• Buffer system: Maintain consistent ionic strength and pH (PBS or TBS systems are common) across block, wash, and diluent buffers to avoid assay drift.
• Compatibility checks: If using biotin–streptavidin detection, confirm that the blocker is biotin-free. For phospho-epitope assays, avoid blockers with high phosphoprotein content.

Item-specific formulation, recommended dilution, and validated incubation parameters are not provided for this product; refer to the CoA/Spec Sheet for definitive directions.

Green Alternatives

This product is an aqueous solution and generally aligns with green chemistry preferences compared with organic solvent-based reagents. Nevertheless, sustainability considerations can still apply.

Considerations (general, literature):

• Aqueous base: Water as the primary solvent reduces VOC emissions and flammability concerns compared with organic blocking formulations.
• Ready-to-use vs. concentrate: Concentrated formats reduce packaging, transport mass, and cold-chain volume. If this item is a concentrate is not specified; consider concentrates when feasible.
• In-house preparation: Making blockers from bulk components (e.g., BSA, casein, fish gelatin) can minimize packaging waste but may increase variability and labor; performance validation is essential.
• Preservatives: Choose preservatives with lower environmental impact and ensure proper disposal of solutions containing biocides.

Comparison (general):

• Commercial aqueous blocker: +consistent performance, +time savings; −packaging waste, −cold-chain footprint.
• DIY protein blocker: +lower cost, +reduced packaging; −batch variability, −validation burden.

Waste reduction tips:

• Prepare only the volume needed per run.
• Reuse reservoirs where compatible with contamination control.
• Consolidate cold shipments with other refrigerated items to reduce transport emissions.

No item-specific eco-certifications are provided; refer to documentation if sustainability badges or compliance information are required.

Pharmaceutical Uses

Not typically applicable. This product is an ELISA blocking reagent for laboratory research workflows and assay development/quality control testing.

Notes:

• It is not an excipient or API and is not intended for clinical manufacturing.
• No pharmacopeial monograph or compendial status is provided for this item.
• Use is restricted to research applications; validate per laboratory SOPs if used in non-clinical analytical assays supporting bioprocess development.

Physical Properties

Item-specific physicochemical specifications are not provided for this product.

• Appearance: Not specified for this item; refer to CoA/Spec Sheet.
• pH, osmolality, conductivity: Not specified for this item; refer to CoA/Spec Sheet.
• Density, refractive index, viscosity: Not specified for this item; refer to CoA/Spec Sheet.
• Molecular weight, formula: Not applicable (formulated mixture).

General/literature expectations for ELISA blocking solutions (for context only; not product specifications):

• Typically aqueous, near-neutral pH (commonly ~7–8, literature), designed to be compatible with polystyrene microplates and downstream antibody incubations.
• May be supplied ready-to-use or as a concentrate (e.g., 5–10×) to be diluted in water or assay buffer (literature). The concentration format for this item is not specified.
• Often formulated to be compatible with common wash buffers (e.g., PBS- or TBS-based systems; literature) and to avoid components that interfere with HRP or AP enzyme readouts.

Always consult the product label and CoA/Spec Sheet for exact, item-specific values and handling guidance.

Quality and Grades

• Grade/Purity: Not specified for this item; refer to CoA/Spec Sheet.

Context for quality in ELISA blocking reagents (general, not claims for this item):

• Low background performance: High-quality blockers provide efficient surface passivation on polystyrene plates, minimizing non-specific adsorption of antibodies and sample proteins.
• Enzyme compatibility: Formulations are typically validated to be compatible with HRP- or AP-based detection systems without inhibiting enzyme turnover or generating spurious signal (literature).
• Matrix effects: Premium products are screened to minimize cross-reactivity with common species (mouse, rabbit, goat) and to reduce interference with biotin–streptavidin systems when applicable (literature). If your assay uses biotin/streptavidin, confirm that the blocker is biotin-free.
• Filtration/clarity: Many solutions are 0.2 µm filtered to remove particulates that can increase well-to-well variability (literature). Filtration status for this item is not specified.
• Preservatives: Some formulations include low levels of antimicrobial agents to enhance shelf life at 2–8°C; verify compatibility with your detection chemistry. Preservative identity/content are not specified for this item.

Recommendation: Consult the CoA/Spec Sheet for lot-specific performance notes (e.g., background OD in blank wells, recommended dilution, filtration, and preservative content) before integrating into validated methods.

Reaction and Applications

This reagent is designed for immunoassay workflows rather than chemical reactions. Its primary application is to reduce nonspecific binding in ELISA.

Use in ELISA (general, literature-based guidance):

• Surface passivation: After plate coating with capture antibody or antigen, a blocking step fills remaining hydrophobic and charge-driven adsorption sites on polystyrene to minimize nonspecific interactions of sample proteins and detection antibodies.
• Signal-to-noise improvement: Effective blocking reduces background OD and improves LOD/LOQ by decreasing well-to-well variability.
• Compatibility: Choose blockers that are compatible with the detection system (e.g., HRP/TMB, AP/pNPP) and do not contain components that mask epitopes or interfere with biotin–streptavidin binding if your assay uses those elements.
• Workflow integration: Blocking is typically followed by sample incubation, washes, detection antibody incubation, further washes, and substrate development. Maintain consistent buffer systems throughout to prevent conformational changes in proteins.

Practical tips (literature):

• Validate blocking time (e.g., 30–120 min at RT or overnight at 2–8°C) and temperature against your specific antigen/antibody pair.
• Optimize wash stringency (salt, detergent content) in combination with the blocker to control background without stripping weak specific interactions.
• Include appropriate blank and no-primary controls to quantify background contributed by the blocker and detection reagents.

Reaction Conditions

Not applicable to chemical reactions. For ELISA workflows, typical incubation parameters are discussed under Buffer Applications and Reaction & Applications.

Item-specific incubation temperatures/times or plate compatibility are not provided for this product; refer to the CoA/Spec Sheet for validated conditions.

Safety and Handling

• GHS classification, Signal word, H-statements, Pictograms: Not specified for this item; refer to SDS.
• Primary hazards: ELISA blocking solutions are typically low hazard aqueous mixtures; however, composition (e.g., proteins, preservatives, surfactants) varies. Treat as a laboratory chemical of unknown hazards and follow institutional safety practices.

Good laboratory practice (general guidance):

• PPE: Lab coat, safety glasses, and appropriate chemical-resistant gloves. Avoid skin and eye contact. Do not ingest or inhale aerosols.
• Handling: Work on clean surfaces to prevent microbial contamination. Avoid cross-contamination between plates and reagents. Cap containers promptly.
• Incompatibilities: Avoid mixing with strong oxidizers or acids/bases unless verified compatible with the specific formulation (literature). Some preservatives may be incompatible with azide-sensitive metals; consult SDS.
• First aid (overview): In case of contact, rinse affected area with water for at least 15 minutes. If inhaled as aerosol, move to fresh air. Seek medical attention if irritation persists. Defer to SDS for authoritative instructions.
• Spill response: Absorb with inert material, collect for disposal as laboratory chemical waste. Rinse area with water.
• Waste disposal: Dispose according to local regulations for aqueous laboratory reagents. If containing biobased components, treat as non-sterile biological chemical waste unless specified otherwise.

Always consult the product-specific SDS for definitive hazard and response information.

Solvent Selection

Not typically applicable. This product is an aqueous ELISA blocking solution intended for direct use in microplate-based immunoassays rather than as a solvent.

General notes (literature):

• Blocking solutions are commonly used with PBS- or TBS-based wash buffers. Maintain ionic strength and pH consistent with primary/secondary antibody diluents to avoid assay drift.
• If diluting concentrates, use high-purity water (e.g., 18 MΩ·cm) or the manufacturer-recommended buffer to avoid introducing surfactants or bioburden that may elevate background.

Storage and Reconstitution

• Storage Conditions (item-specific): Store at 2–8°C.
• Shipped In (item-specific): Wet ice.
• Format: Not specified for this item (ready-to-use vs. concentrate); refer to label/CoA.

General handling guidance (literature):

• Mixing: Upon receipt, allow to equilibrate to room temperature, then gently invert to homogenize. Avoid vortexing if proteinaceous to prevent foaming.
• Aliquoting: If frequent use is expected, consider aliquoting to minimize repeated warm/cold cycles. Do not freeze unless the CoA explicitly permits freezing; many blockers can precipitate or lose performance upon freeze–thaw.
• Sterility: Unless stated otherwise, assume non-sterile; avoid touching the bottle mouth and use clean reservoirs and multichannel tips to minimize contamination.
• Reconstitution (if a concentrate): Dilute with high-purity water or the recommended buffer (e.g., PBS/TBS) to the working concentration specified on the label. Mix gently until uniform.
• Shelf life: Not specified for this item; refer to CoA/Spec Sheet. Discontinue use if turbidity, precipitate, or microbial growth is observed.

Always follow the product label and CoA/Spec Sheet for definitive storage and handling instructions.

Structure and Identity

This product is a formulated reagent for immunoassays rather than a single, well-defined compound.

• Product Type: ELISA blocking solution (formulated mixture)
• CAS: Not assigned for formulated mixtures.
• Molecular formula / MW / InChIKey / SMILES: Not applicable to mixtures; not specified for this item.
• Composition: Not specified for this item; refer to CoA/Spec Sheet.

Structural description (general information):

• ELISA blocking solutions commonly contain proteins (e.g., serum proteins, casein, BSA), peptides, or synthetic polymers, plus buffer salts and optional preservatives (literature). Exact components for SKU E615777 are not specified.
• Functional role is physicochemical rather than structural: components adsorb non-specifically to hydrophobic or charged microplate surfaces to minimize background binding (literature).

Item-specific identifiers provided:

• SKU: E615777
• Category Path: 全部 / 可售 / 抗体
• Research Use Note: For research use only

Synthetic Utility

Not applicable. ELISA blocking solutions are not used as synthetic building blocks or reagents in organic or inorganic synthesis.

For chemical synthesis needs, refer to solvents, catalysts, and reagents within the appropriate catalog sections.

Target Specificity

Not applicable. This product is a blocking solution and does not possess antigen/epitope specificity.

• No clone, isotype, or species reactivity information applies.